Form 4 for COYA Coya Therapeutics, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2023-08-22 · accession 0001493152-24-008916 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-03-05 | 2023-08-22 | COYA | Lee Ann | Dir | P - Purchase | $3.62 | +1,000 | 17.5K | +6% | +$3,620 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2023-08-22 | P | A | 1,000 | $3.62 | 17,479 | I By Spouse IRA | — | — | (F1) Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request. |